| Health / Medical Topics |
Crenolanib Besylate
The besylate salt form of crenolanib, an orally bioavailable benzimidazole targeting the platelet-derived growth factor receptor (PDGFR) subtypes alpha and beta and FMS-related tyrosine kinase 3 (Flt3), with potential antineoplastic activity. Upon oral administration, crenolanib binds to and inhibits both wild-type and mutated forms of PDGFR and Flt3, which may result in the inhibition of PDGFR- and Flt3-related signal transduction pathways. This results in inhibition of tumor angiogenesis and tumor cell proliferation in PDGFR and/or Flt3 overexpressing tumor cells. PDGFR and Flt3, class III receptor tyrosine kinases, are upregulated or mutated in many tumor cell types. (NCI Thesaurus)
YOU MAY ALSO LIKE
An orally bioavailable benzimidazole targeting the platelet-derived growth factor receptor (PDGFR) subtypes alpha and beta and FMS-related tyrosine kinase 3 (Flt3), with…
The determination of the number of crenated red blood cells present in a sample.
A characteristic of a medicinal product, specifying that its most predominant agreeable savor detected by the unified sensation of taste and olfactory…
A document that qualifies somebody to do something, provides authentication for a claim, or confirms position or status.
Human CREBL2 wild-type allele is located in the vicinity of 12p13 and is approximately 33 kb in length. This allele, which encodes…
This gene plays a role in transcriptional regulation and mediates DNA-binding interactions.
